CD274 and neoplasm: This retrospective longitudinal study evaluated the prevalence of PD-L1 expression (as assessed by CPS ≥1) and identified an association of tumor PD-L1 (CPS ≥1) expression with shorter OS in response to first-line SOC therapy in patients with ten prespecified solid tumor types.